We validated that both GBM stem cell subtypes expressed the stem cell marker SOX2 as well as subtype‐specific markers, such as OLIG2 and BAALC (PN) or CD44 (MS‐like subtype) (Fig. S8C,D). The gene discussed is CD44; the disease is glioblastoma.